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Background
Infection with the Human T-Lymphotropic Virus 1
(HTLV-1) is associated with bronchiectasis in Indigen-
ous Australians [1]. The present study defines the clini-
cal presentation and outcomes of bronchiectasis
according to HTLV-1 serostatus in this population.
Materials and methods
Retrospective cohort study at Alice Springs Hospital,
central Australia. Medical records were reviewed for all
Indigenous adults admitted between 2000-2006 with
radiologically confirmed bronchiectasis and known
HTLV-1 serostatus.
Results
One-hundred and twenty patients were admitted dur-
ing the study period, HTLV-1 serology was performed
for 92 (75.8%) patients. Western blots confirmed
HTLV-1 infection in 52 (58.4%) cases and were inde-
terminate for 3 patients. HTLV-1 seropositive patients
more often had bilateral bronchiectasis (HTLV-1+, 37/
51; HTLV-1-, 18/36; p=0.032) and ground glass opaci-
ties (HTLV-1+, 10/51; HTLV-1-, 1/36; p=0.028) on
HRCT chest, but were less likely to have a pathogen
isolated during an infective exacerbation (HTLV-1+,
16%; HTLV-1-, 20%; p=0.042). HTLV-1 seropositive
patients were more likely to have cor pulmonale
(HTLV-1+, 10/52; HTLV-1-, 1/37; p=0.023) and to suf-
fer bronchiectasis-related deaths (OR 5.78; 95% CI,
1.17, 26.75; p=0.028). The mortality rate for the entire
cohort during the 7 year period was 34.2%. Median age
of death for both groups combined was 42.5 years.
Only HTLV-1 seropositive patients were admitted for
treatment of infected skin lesions and this was the
major predictor of subsequent death from any cause
on multivariable analysis (OR, 6.77, 95% CI, 1.46,
31.34; p=0.014).
Conclusion
In an Indigenous Australian cohort HTLV-1 infection is
associated with bronchiectasis and an increased risk of
pulmonary hypertension and death.
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